Subjects: DOENÇAS CARDIOVASCULARES, INSUFICIÊNCIA RENAL, DOENÇAS CARDIOVASCULARES
ABNT
MARIN-NETO, José Antônio. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet, v. 372, n. 9638, p. 547-553, 2008Tradução . . Acesso em: 19 set. 2024.APA
Marin-Neto, J. A. (2008). Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet, 372( 9638), 547-553.NLM
Marin-Neto JA. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet. 2008 ; 372( 9638): 547-553.[citado 2024 set. 19 ]Vancouver
Marin-Neto JA. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet. 2008 ; 372( 9638): 547-553.[citado 2024 set. 19 ]